Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: the Canadian context
Abstract Background Patients use medical cannabis for a wide array of illnesses and symptoms, and many substitute cannabis for pharmaceuticals. This substitution often occurs without physician oversight, raising patient safety concerns. We aimed to characterize substitution and doctor-patient commun...
Saved in:
Main Authors: | Alexis Holman (Author), Daniel J. Kruger (Author), Philippe Lucas (Author), Kaye Ong (Author), Rachel S. Bergmans (Author), Kevin F. Boehnke (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution
by: Kevin F. Boehnke, et al.
Published: (2021) -
The impact of non-medical cannabis legalization and other exposures on retention in longitudinal cannabis research: a survival analysis of a prospective study of Canadian medical cannabis patients
by: Philippe Lucas, et al.
Published: (2021) -
The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer
by: Philippa Hawley, et al.
Published: (2020) -
Regulating compassion: an overview of Canada's federal medical cannabis policy and practice
by: Lucas Philippe G
Published: (2008) -
Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients
by: Philippe Lucas, et al.
Published: (2019)